Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01125202 · ClinicalTrials.gov registry record · NA
Intervention to Reduce Dietary Sodium in Hemodialysis
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT01125202 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 179 participants.
The verdict
NCT01125202, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of life. The primary study hypotheses are that participants will gain less weight in between dialysis treatments, and that dietary recalls will demonstrate reduced consumption of dietary sodium.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL SCT-based behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01125202
The ClinicalTrials.gov registry entry for NCT01125202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT01125202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01125202 about?
NCT01125202 is a clinical study titled "Intervention to Reduce Dietary Sodium in Hemodialysis". The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of ...
What is the current status of trial NCT01125202?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2009-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01125202?
The interventions under investigation include: Attention Control (BEHAVIORAL), SCT-based behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01125202?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.